Delivery Order SPE2DR25D1109-SPE2DR26FFM0B
Award Date 1/30/26
Potential Completion Date 2/2/26
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,065.08 to AmerisourceBergen Drug Corp for the supply of Glimepiride 1 mg tablets in quantities of 100 units. This firm fixed-price contract was competitively awarded without set-aside provisions and is scheduled for completion by December 19, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,635.07 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100 count) on January 29, 2026, with an ultimate completion date of January 30, 2026. This non-set-aside contract was competitively awarded on a firm fixed-price basis and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is...
- The Defense Logistics Agency awarded a delivery order valued at $3,019.18 to Amerisourcebergen Drug Corp for the supply of Glimepiride 2 mg tablets (100-count packages) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price, non-set-aside contract represents a task order under Amerisourcebergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,834.01 to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Glimepiride 2 mg tablets (100 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 16, 2026 and performance to be executed at the contractor's Conshohocken, Pennsylvania facility. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,583.75 delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Glimepiride 2 mg tablets in quantities of 100. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by January 7, 2026. The place of performance is AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a discrete task under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $2,871.86 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count bottles) on January 23, 2026, with an ultimate completion date of January 26, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The awardee, AmerisourceBergen Drug Corp, is a subsidiary of Cencora, Inc., and operates from its corporate headquarters in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,280.16 to Amerisourcebergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units). This firm fixed-price contract, issued on January 20, 2026, with completion scheduled for January 21, 2026, represents a non-set-aside competitive award. Amerisourcebergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets in quantities of 100 units under a firm fixed-price contract valued at $1,411.27. The order, issued on January 5, 2026, with an ultimate completion date of January 6, 2026, represents a non-competitive delivery order executed under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $5,259.83 to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This competitively awarded, firm fixed-price contract contains no set-aside designation. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glimepiride 4 mg tablets (100-count units) with a ceiling value of $1,229.86. The award, issued on December 18, 2025, with an ultimate completion date of December 19, 2025, represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical federal...